Similar articles for PMID: 24166106

Year	Number of Results
1999	1
2000	2
2001	1
2002	2
2003	3
2004	2
2005	6
2006	6
2007	11
2008	12
2009	11
2010	10
2011	9
2012	16
2013	10
2014	8
2015	4
2016	3
2017	7
2018	4
2019	4
2020	1
2021	1
2024	0

1

Safety and pharmacology of gemcitabine and capecitabine in patients with advanced pancreatico-biliary cancer and hepatic dysfunction.

Joerger M, Huitema AD, Koeberle D, Rosing H, Beijnen JH, Hitz F, Cerny T, Schellens JH, Gillessen S. Joerger M, et al. Cancer Chemother Pharmacol. 2014 Jan;73(1):113-24. doi: 10.1007/s00280-013-2327-2. Epub 2013 Oct 29. Cancer Chemother Pharmacol. 2014. PMID: 24166106

2

Cetuximab, gemcitabine and capecitabine in patients with inoperable biliary tract cancer: a phase 2 study.

Rubovszky G, Láng I, Ganofszky E, Horváth Z, Juhos E, Nagy T, Szabó E, Szentirmay Z, Budai B, Hitre E. Rubovszky G, et al. Eur J Cancer. 2013 Dec;49(18):3806-12. doi: 10.1016/j.ejca.2013.07.143. Epub 2013 Sep 2. Eur J Cancer. 2013. PMID: 24007821 Clinical Trial.

3

Optimizing the administration of fixed-dose rate gemcitabine plus capecitabine using an alternating-week schedule: a dose finding and early efficacy study in advanced pancreatic and biliary carcinomas.

Ko AH, Espinoza AM, Jones KA, Venook AP, Bergsland EK, Kelley RK, Dito E, Ong A, Hanover CS, Coakley FV, Tempero MA. Ko AH, et al. Am J Clin Oncol. 2012 Oct;35(5):411-7. doi: 10.1097/COC.0b013e3182185888. Am J Clin Oncol. 2012. PMID: 21552099 Clinical Trial.

4

Phase I trial of gemcitabine combined with capecitabine and erlotinib in advanced pancreatic cancer: a clinical and pharmacological study.

Francois E, Bennouna J, Chamorey E, Etienne-Grimaldi MC, Renée N, Senellart H, Michel C, Follana P, Mari V, Douillard JY, Milano G. Francois E, et al. Chemotherapy. 2012;58(5):371-80. doi: 10.1159/000343969. Epub 2012 Dec 11. Chemotherapy. 2012. PMID: 23235319 Clinical Trial.

5

Three-weekly oxaliplatin combined with gemcitabine and capecitabine in the first-line treatment of patients with advanced biliary tract cancer.

Petrioli R, Roviello G, Fiaschi AI, Laera L, Roviello F, Marrelli D, Francini E. Petrioli R, et al. Anticancer Drugs. 2015 Jul;26(6):682-6. doi: 10.1097/CAD.0000000000000233. Anticancer Drugs. 2015. PMID: 25811963

6

Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancers.

Kessler ER, Eckhardt SG, Pitts TM, Bradshaw-Pierce EL, O'byrant CL, Messersmith WA, Nallapreddy S, Weekes C, Spratlin J, Lieu CH, Kane MA, Eppers S, Freas E, Leong S. Kessler ER, et al. Invest New Drugs. 2016 Apr;34(2):176-83. doi: 10.1007/s10637-015-0316-5. Epub 2015 Dec 30. Invest New Drugs. 2016. PMID: 26715573 Free PMC article. Clinical Trial.

7

A phase II trial of fixed-dose rate gemcitabine plus capecitabine in metastatic/advanced biliary tract cancer patients.

Santini D, Virzi V, Vasile E, Vincenzi B, Catalano V, Graziano F, Masi G, Bronte G, Russo A, Falcone A, Tonini G. Santini D, et al. Oncology. 2012;82(2):75-82. doi: 10.1159/000329079. Epub 2012 Feb 7. Oncology. 2012. PMID: 22327844 Free article. Clinical Trial.

8

Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma.

Cho JY, Paik YH, Chang YS, Lee SJ, Lee DK, Song SY, Chung JB, Park MS, Yu JS, Yoon DS. Cho JY, et al. Cancer. 2005 Dec 15;104(12):2753-8. doi: 10.1002/cncr.21591. Cancer. 2005. PMID: 16294346 Free article. Clinical Trial.

9

Capecitabine and celecoxib as second-line treatment of advanced pancreatic and biliary tract cancers.

Pino MS, Milella M, Gelibter A, Sperduti I, De Marco S, Nuzzo C, Bria E, Carpanese L, Ruggeri EM, Carlini P, Cognetti F. Pino MS, et al. Oncology. 2009;76(4):254-61. doi: 10.1159/000205388. Epub 2009 Feb 26. Oncology. 2009. PMID: 19246950 Clinical Trial.

10

Phase I study of biweekly oxaliplatin, gemcitabine and capecitabine in patients with advanced upper gastrointestinal malignancies.

Tan BR, Brenner WS, Picus J, Marsh S, Gao F, Fournier C, Fracasso PM, James J, Yen-Revollo JL, McLeod HL. Tan BR, et al. Ann Oncol. 2008 Oct;19(10):1742-8. doi: 10.1093/annonc/mdn375. Epub 2008 Jun 4. Ann Oncol. 2008. PMID: 18534963 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

113 results

Results by year